![Allergy therapeutics plc](https://directorstalk.net/wp-content/uploads/2015/10/Allergy-therapeutics-plc.png)
Allergy Therapeutics achieve good sales growth in 2019
Allergy Therapeutics (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announced preliminary results for the year ended 30 June 2019. Highlights Financial Highlights · 8% revenue growth